Andrew Penn RN, MS, NP, CNS, APRN-BC, UC San Francisco trained psychiatric nurse practitioner. Associate clinical professor in the UCSF School of Nursing, practicing at the San Francisco VA. He has worked as study therapist on a MDMA-assisted therapy protocol for PTSD.  

Speaker Disclosures:

Financial: Andrew Penn has employment relationships with UCSF School of Nursing, San Francisco Veterans Administration Hospital, Multidisciplinary Association for Psychedelics Studies, Usona Institute, Filament, and Texas Tech University. He receives a consulting fee from Alexander Shulgin Research Institute and MindMed and a speaking honorarium from Compass Pathways, NACCME, and Psycom pro. Andrew Penn serves on the advisory board for Osmind and Tactogen. He receives a speaking honorarium and recording royalties from PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.

Non-financial: Andrew Penn is an advisor for Brain Futures Foundation, the Board of Psychedelic Medicine and Therapies, and the British Transpersonal Association. He is an editor for several peer review journals, for a complete list contact PESI, Inc. Andrew Penn is the co-founder of the Organization of Psychedelic and Entheogenic Nurses. He is the founder of the UCSF School of Nursing Psychedelic Therapy Journal Club. Andrew Penn is a member of the American Psychiatric Nurses Association.